DHA sbir phase II H2-0245

Ended Definitive Contract Awarded Last action

Contract number
W81XWH17C0212
Awardee
Awarding agency
Obligated
$998,967

Award facts

Opportunity
  • HQ003416R1CDB Solicitation number
Contract value 100% obligated
$998,967.41 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Defense Health Agency Department of Defense
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 27 offers Negotiated Proposal / Quote
Pricing
Fixed Price Level of Effort
Place of performance
Vallejo, CA 94590, USA
Research
SBIR Program Phase II Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 · Medical research and development contract $0
Supplemental Agreement for work within scope P00001 · Medical research and development contract DHA sbir phase II H2-0245 topic number DHA16-012 research title: novel super-cooling of genitourinary cells and… $0
Original award $998,967

About this award

The Defense Health Agency awarded a $998,967 Small Business Innovation Research (SBIR) Phase II contract to X-Therma Inc., a minority-owned, woman-owned small business, on September 25, 2017. The contract, designated DHA SBIR PHASE II H2-0245, was awarded under the Total Small Business set-aside program with a fixed-price level-of-effort structure and a completion date of February 24, 2020. X-Therma Inc. performed the work at its facility in Vallejo, California, developing advanced biopreservation solutions to address critical challenges in organ transplantation and cell therapy.

X-Therma Inc. specializes in regenerative medicine and organ preservation technology, leveraging bioinspired next-generation cryoprotectants to extend the viability window of biological materials during storage and transport. Under this DHA-funded SBIR Phase II contract, the company advanced ex vivo preservation techniques for vascularized composite allografts at high subzero temperatures, building on previous Phase I research. This effort complements concurrent federal investments in the company's work, including substantial grants from the National Institutes of Health focused on porcine kidney preservation with the goal of extending the ischemia window to 120 hours, positioning X-Therma Inc. as a key innovator in improving outcomes for organ transplant patients.

Quick answers

Who was awarded contract W81XWH17C0212?

W81XWH17C0212 was awarded to X-Therma Inc. by Medical Command (Department of the Army) on September 21, 2017.

How much is contract W81XWH17C0212 worth?

The government has obligated $998,967 on W81XWH17C0212.

Which agency awarded contract W81XWH17C0212?

Medical Command (Department of the Army) awarded W81XWH17C0212, with funding from Defense Health Agency (Department of Defense).

Was contract W81XWH17C0212 competed?

The extent of competition for W81XWH17C0212 was full and open competition after exclusion of sources. The government received 27 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award